Novacyt (XPAR:ALNOV) Total Current Assets : €139.68 Mil (As of Jun. 2023)

View and export this data going back to 2012. Start your Free Trial

What is Novacyt Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Novacyt's total current assets for the quarter that ended in Jun. 2023 was €139.68 Mil.

Novacyt Total Current Assets Historical Data

The historical data trend for Novacyt's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novacyt Total Current Assets Chart

Novacyt Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Current Assets

Get a 7-Day Free Trial

10.05

6.96

226.48

186.87

146.30

Novacyt Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Total Current Assets	Get a 7-Day Free Trial															178.02	186.87	165.52	146.30	139.68

Novacyt Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Novacyt's Total Current Assets for the fiscal year that ended in Dec. 2022 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	100.013	+	29.148	+	3.48	+	13.659
	=	146.30

Novacyt's Total Current Assets for the quarter that ended in Jun. 2023 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	95.264	+	29.181	+	2.866	+	12.371
	=	139.68

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Novacyt (XPAR:ALNOV) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Novacyt's Liquidation Value for the quarter that ended in Jun. 2023 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	95.264	-	28.946	+	0.75 * 29.09	+	0.5 * 2.866
=	89.57

Novacyt Total Current Assets Related Terms

Thank you for viewing the detailed overview of Novacyt's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Novacyt (XPAR:ALNOV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Novacyt SA (XPAR:ALNOV) » Definitions » Total Current Assets

Comparable Companies

Traded in Other Exchanges

NVYTF:USA NCYT:UK NYZ:Germany

Address

13, Avenue Morane Saulnier, Velizy-Villacoublay, FRA, 78140

Website

https://www.novacyt.com

Novacyt SA is engaged in developing and selling diagnostic products for cancer and infectious diseases. The company operates its business through the following business segments. Primerdesign is the designer, manufacturer, and marketer of molecular 'real-time' qPCR testing devices and reagents in the areas of infectious diseases based in Southampton, UK: IT-IS International segment develops PCR devices for the life sciences and food testing industry and Corporate segment.

Novacyt (XPAR:ALNOV) Headlines

No Headlines